KEAP1 and schizophrenia: A recent study showed that the expressions of Keap1 and Nrf2 in the parietal cortex from patients with schizophrenia were lower than those of controls, suggesting that Keap-Nrf2 signaling may play a role in the pathophysiology of schizophrenia38.